Priority Date: 22.06.12 (US 201261662977P)

IMIDAZO BICYCLIC IMMINIUM COMPOUNDS AS ANTITUMOR AGENTS

  • Application ID: EP13807852
  • Status: PATENT GRANTED

Attorney

operating since 1927
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 22.06.2012 - Priority Date (US 201261662977P)
  • 27.12.2013 - Publication A1 (WO2013192301)
  • 29.04.2015 - Publication A1 (EP2864332)
  • 28.12.2016 - Publication B1 (EP2864332)